tiprankstipranks
Molecular Partners (MLLCF)
:MLLCF
US Market

Molecular Partners AG (MLLCF) Financial Statements

Compare
11 Followers

Molecular Partners AG Financial Overview

Molecular Partners AG's market cap is currently $192.88M. The company's EPS TTM is $-2.145; its P/E ratio is ―; Molecular Partners AG is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 7.04M$ 189.54M$ 9.33M--
Operating Income$ -60.26M$ 115.93M$ -63.84M$ -58.33M$ -36.66M
EBITDA-$ 120.24M$ -61.22M$ -59.59M$ -33.74M
Net Income$ -61.98M$ 123.17M$ -55.78M$ -62.76M$ -36.29M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 198.35M$ 262.26M$ 172.67M$ 187.55M$ 104.94M
Total Debt$ 3.65M$ 4.85M$ 6.04M$ 7.22M$ 2.54M
Net Debt$ -183.24M$ -244.29M$ -126.77M$ -166.50M$ -92.53M
Total Liabilities$ 21.92M$ 27.09M$ 65.38M$ 80.33M$ 50.80M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -59.81M$ 117.15M$ -92.26M$ -30.67M$ -3.05M
Operating Cash Flow$ -59.01M$ 118.57M$ -90.95M$ -28.98M$ -1.19M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Molecular Partners AG Earnings and Revenue History

Molecular Partners AG Debt to Assets

Molecular Partners AG Cash Flow

Molecular Partners AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis